← Back to guidelines
Dermatology48 papers

Subcutaneous morphea

Last edited: 4/15/2026

Overview

Morphea, or localized scleroderma, is an immune-mediated disorder characterized by skin fibrosis that can extend to underlying tissues such as fascia, muscle, and bone 13.

Diagnosis

  • Clinical presentation includes skin thickening and hardening, often with a violaceous hue 1.
  • Linear, plaque, and generalized subtypes are recognized based on extent and distribution 1.
  • Biopsy may be necessary to confirm diagnosis and rule out other conditions 1.
  • No specific grading system universally adopted; clinical assessment and imaging may aid in severity evaluation 1.
  • Management

  • First-line treatments: Topical corticosteroids are commonly used 13.
  • Adjunctive therapies: Methotrexate for refractory cases, though specific dosing details are not provided 1.
  • Other considerations: Limited evidence supports other systemic therapies; individualized treatment plans are advised 3.
  • Special Populations

  • Pediatrics: Pediatric morphea often responds to treatment, with topical therapies showing efficacy 1.
  • Comorbidities: Specific management adjustments for comorbidities are not detailed in the provided abstracts 1.
  • Key Recommendations

  • Initiate treatment with topical corticosteroids for localized morphea (Evidence: Moderate 13).
  • Consider methotrexate for patients who do not respond to topical treatments, though evidence is derived from observational studies (Evidence: Weak 1).
  • Regular follow-up is essential to monitor response and adjust therapy as needed, particularly in pediatric patients (Evidence: Expert opinion 1).
  • References

    1 Bağlan E, Kızıldağ Z, Çağlayan Ş, Çakmak F, Yener GO, Özdel S et al.. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG). Clinical rheumatology 2023. link 2 Abate DA, Ayele MH, Mohammed AB. Subcutaneous mycoses in Ethiopia: a retrospective study in a single dermatology center. Transactions of the Royal Society of Tropical Medicine and Hygiene 2021. link 3 Fett NM. Morphea: evidence-based recommendations for treatment. Indian journal of dermatology, venereology and leprology 2012. link

    Original source

    1. [1]
      Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).Bağlan E, Kızıldağ Z, Çağlayan Ş, Çakmak F, Yener GO, Özdel S et al. Clinical rheumatology (2023)
    2. [2]
      Subcutaneous mycoses in Ethiopia: a retrospective study in a single dermatology center.Abate DA, Ayele MH, Mohammed AB Transactions of the Royal Society of Tropical Medicine and Hygiene (2021)
    3. [3]
      Morphea: evidence-based recommendations for treatment.Fett NM Indian journal of dermatology, venereology and leprology (2012)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG